Just The News
The Department of Commerce on Monday revealed that it has launched an investigation into the national security risks of importing some pharmaceuticals, which will give President Donald Trump the authority to limit imports deemed a threat.
The move is seen as a precursor to Trump’s eventual tariffs on prescription drugs. The president teased the tariffs on pharmaceuticals last week, stating an official decision will be made in the coming weeks. MORE
Why not look into the implications and effects of protecting the worthless western medical and pharmaceutical cartel with government power, actions, and regulations over FREEDOM and a marketplace of superior alternatives?
Good.
Now ban mRNA.
That we even got to this point of drug dependence with China and India is a crime.
What SNS said…
There are lots of American Pharma and Bio-tech companies that are running at half production or less. Most are more heavier into research than production but they have the production facilities that see little use. It would not take much to ramp up production on generic anti-biotics.
Generics?
We don’t need no steenkin generics!
Phizer
Albert Bourla disapproves of this post.